» Articles » PMID: 17525072

Ethnic Variation in Childhood Asthma and Wheezing Illnesses: Findings from the Millennium Cohort Study

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2007 May 26
PMID 17525072
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is not clear how respiratory morbidity during early childhood varies across ethnic groups in the UK. This article seeks to determine whether asthma and wheeze illnesses during early childhood differ across ethnic groups and what factors explain observed differences.

Methods: Data from the UK Millennium Cohort Study on 14,630 children were analyzed from the second sweep of interviews. Parental interviews were conducted when the cohort member was aged approximately 3(1/2) years. Data collected included the occurrence of asthma and wheezing symptoms, biological and socio-economic factors and markers of cultural tradition.

Results: At age 3, 12.3% (n = 1,902) of children had ever had asthma and 20.0% (n = 3,030) had wheezed in the last 12 months. 18.2% of Black Caribbean children and 5.0% of Bangladeshi children reported ever asthma compared with 11.6% of White children. 25.5% of Black Caribbean children and 8.7% of Bangladeshi reported recent wheeze compared with 19.4% of White children. After adjustments, the disadvantage in asthma and recent wheeze for Black Caribbeans was mostly explained by socio-economic factors (adjusted odds ratios (OR) for asthma 1.42, 95% confidence interval (CI) 0.96-2.09; recent wheeze 1.18, 0.85-1.64). The Bangladeshi advantage lost statistical significance, mostly due to adjustment for markers of cultural tradition (adjusted OR for asthma 0.40, 95% CI 0.15-1.09; recent wheeze 0.44, 0.18-1.19).

Conclusion: Our results point to the need to locate child health within the unique context of each ethnic group and to recognize that potential explanations for observed differences do not necessarily hold for all groups.

Citing Articles

Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study.

Lo D, Lawson C, Gillies C, Shabnam S, Gaillard E, Pinnock H Thorax. 2024; 79(11):1050-1059.

PMID: 38955499 PMC: 11503080. DOI: 10.1136/thorax-2023-221210.


Pharmacoequity in Allergy-Immunology: Disparities in Access to Medications for Allergic Diseases and Proposed Solutions in the United States and Globally.

Maldonado-Puebla M, Akenroye A, Busby J, Cardet J, Louisias M J Allergy Clin Immunol Pract. 2023; 12(2):272-280.

PMID: 37951413 PMC: 10922722. DOI: 10.1016/j.jaip.2023.11.005.


Burden of allergic disease among ethnic minority groups in high-income countries.

Jones C, Paudyal P, West R, Mansur A, Jay N, Makwana N Clin Exp Allergy. 2022; 52(5):604-615.

PMID: 35306712 PMC: 9324921. DOI: 10.1111/cea.14131.


Disadvantage in early-life and persistent asthma in adolescents: a UK cohort study.

Creese H, Lai E, Mason K, Schluter D, Saglani S, Taylor-Robinson D Thorax. 2021; 77(9):854-864.

PMID: 34650003 PMC: 9411911. DOI: 10.1136/thoraxjnl-2021-217312.


Understanding Covid and the associated post-infectious hyper-inflammatory state (PIMS-TS) in children.

Riphagen S Med Hypotheses. 2020; 144:110029.

PMID: 32758875 PMC: 7313490. DOI: 10.1016/j.mehy.2020.110029.